NTRB Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings

Based on 7 analysts giving stock ratings to Nutriband Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
29
Buy
57
Hold
14
Sell
0
Strong Sell
0
Nutriband Inc

Nutriband Inc. Stock Analysis NTRB

United States Health Care Micro Cap
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. The company is headquartered in Orlando, Florida. The company went IPO on 2017-06-20. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. The company is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Read More

NTRB Chart

United States flagUnited States Health Care Micro Cap

Nutriband Inc vs S&P 500 Comparative Returns

Analysis of NTRB stock performance compared to the broader market (S&P 500) across multiple timeframes.

YTD Performance
  • Nutriband Inc (NTRB) 46.92%
  • S&P 500 8.2%
Nutriband Inc Outperformed S&P 500 by 38.72%
1Y Performance
  • Nutriband Inc (NTRB) 28.15%
  • S&P 500 17.63%
Nutriband Inc Outperformed S&P 500 by 10.52%
3Y Performance
  • Nutriband Inc (NTRB) 68.55%
  • S&P 500 54.54%
Nutriband Inc Outperformed S&P 500 by 14.01%
5Y Performance
  • Nutriband Inc (NTRB) -19.27%
  • S&P 500 94.73%
Nutriband Inc Underperformed S&P 500 by 114.00%

Key Statistics of Nutriband Inc(NTRB)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$6.83$7.15

Today's Open

$6.97

Volume

22.87K

P/E Ratio (TTM)

-

52 Week Range

$3.72$11.78

Market Cap

96.71M

Avg. Volume

41.93K

Dividend Yield

-

Financial Metrics & Statements of Nutriband Inc(NTRB)

  • Per Share Data
  • Ratios
  • Statements
Currency: USD20202021202220232024
Revenue per Share (TTM)
0.06 0.13 0.16 0.27 0.24
EBIT per Share (TTM)
-0.31 -0.36 -0.43 -0.53 -0.55
Earnings per Share (EPS) (TTM)
- - -0.94 - 0
EPS Forward
- - - -0.53 -0.69
  • Annual Icon Annual
  • Quarterly Icon Quarterly
Currency: USD20202021202220232024
Net Margin
-7.34 -3.11 -4.34 -2.16 -2.63
Quick Ratio
0.01 0.1 6.37 2.8 0.64
Current Ratio
0.02 0.12 7.02 3.6 1.02
Price to Book
423.75 15.51 2.86 3.33 3.18
Gross Margin
-0.48 0.38 0.35 0.36 0.41
Return on Assets
-1.24 -0.3 -0.48 -0.47 -0.73
Return on Invested Capital
-5.59 -0.33 -0.52 -0.52 -0.83
Long-Term Debt to Equity
0 0.02 0.01 0.01 0.01
Total Debt to Total Asset
0.14 0.18 0.01 0.01 0.03
Long-Term Debt to Total Asset
0 0.02 0.01 0.01 0.01
Total Debt to Total Capital
0.64 0.2 0.01 0.01 0.03
Operating Margin
-5.31 -2.83 -4.26 -2.15 -2.6
Price to Earning
- - -3.83 - -

FAQ's

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.